MedBridge Healthcare, a provider of sleep disorder diagnostic services and treatment, announced that Ghentry Pace will be joining the company as its chief executive officer.
Pace brings more than 20 years of healthcare experience in clinical, operational, and financial arenas. He has held executive leadership roles in integrated healthcare systems, such as Intermountain Healthcare, and a number of Fortune 500 healthcare providers, including Apria Healthcare and Conifer Health Solutions (owned by Tenet Healthcare and Catholic Health Initiatives). Most recently, he served as the Senior Revenue Cycle leader for dialysis provider Fresenius Medical Care.
“Ghentry has a history of successful healthcare leadership and extensive knowledge of the sleep disorder diagnosis and respiratory therapy markets,” says Klaus Koch, the chairman of the board of MedBridge Healthcare, in a release. “We are very excited to have him join the MedBridge team.”
“MedBridge provides innovative patient care solutions and has developed the best practices to better serve the population of more than 70 million people suffering from chronic sleep disorders. Ghentry brings a passion and commitment to patient care that is completely aligned with our culture and values,” says David Leete, MedBridge Healthcare’s vice president of finance.
In his role as MedBridge Healthcare’s CEO, Pace will lead a staff of 545 direct services, sleep and respiratory professionals in MedBridge’s mission to engage and support patients suffering from chronic sleep, respiratory, and related healthcare disorders.
“We are pleased to welcome Ghentry to our team at MedBridge as we work to diagnose and treat patients challenged with sleep disorders, with the larger goal of reducing the exacerbation of other serious chronic health conditions, and in parallel striving to reduce the overall cost of care,” says Mark Shaver, vice president of business development and strategic alliances for Johns Hopkins Medicine and MedBridge Healthcare board member.
“We believe that MedBridge Healthcare sets the standard for the diagnosis and treatment of sleep disorders and are confident that the addition of Ghentry Pace to our executive team will lead to the continued improvement and growth of these important services in the markets that we serve,” says John Mathias, chief development officer at MedBridge Healthcare.
